Document is current
Any future updates will be listed below
-
Authors
Hsu, Chih-Chin https://orcid.org/0000-0002-5558-3456
Wang, Jong-Shyan
Shyu, Yu-Chiau
Fu, Tieh-Cheng
Juan, Yu-Hsiang
Yuan, Shin-Sheng
Wang, Chao-Hung
Yeh, Chi-Hsiao
Liao, Po-Cheng
Wu, Hsin-Yi
Hsu, Pang-Hung
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04038723 at ClinicalTrials.govDocuments that mention this clinical trial
Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients
https://doi.org/10.1186/s12967-023-04032-7
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 104-2314-B-182-004)
Ministry of Science and Technology, Taiwan (105-2314-B-182-010)
Keelung Chang Gung Medical Research Program (CMRPG2G0021)
Keelung Chang Gung Medical Research Program (CMRPG2I0091)
Keelung Chang Gung Medical Research Program (CMRPG2G0051)
Keelung Chang Gung Medical Research Program (CMRPG2L0251)
- License Information
-
More Information
Article History
Received: 27 October 2022
Accepted: 1 March 2023
First Online: 10 March 2023
Declarations
:
: The study was performed in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Chang Gung Medial Foundation (ref. 103-7333A3 and 104-9800A3), and the Clinical Trial Registry number is NCT04038723. All participants received a detailed explanation of the procedure, methods, and objectives of the study and the research and had to agree via written informed consent.
: No identifiable details are present in the manuscript and related material.
: All authors have read the journal’s policy on disclosure of potential conflicts of interest. The authors declare that they have no conflicts of interest.
